BioNexus Gene Lab (BGLC) Accumulated Depreciation & Amortization (2019 - 2026)
BioNexus Gene Lab recorded quarterly Accumulated Depreciation & Amortization of $966160.0 in Q1 2026, up 2.31% quarter-over-quarter from $944345.0 in Q4 2025, and down 2.89% year-over-year from $994915.0 in Q1 2025.
BioNexus Gene Lab's Accumulated Depreciation & Amortization history runs 8 years deep, the most recent figure standing at $966160.0 for Q1 2026.
- In Q1 2026, Accumulated Depreciation & Amortization fell 2.89% year-over-year to $966160.0; the TTM figure through Mar 2026 stood at $966160.0 (down 2.89% YoY), while the FY2025 annual figure was $944345.0, down 3.95% from the prior year.
- Accumulated Depreciation & Amortization came in at $966160.0 for Q1 2026 at BioNexus Gene Lab, up from $944345.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $994915.0 in Q1 2025 to a low of -$1.5 million in Q1 2022.
- A 5-year average of $610413.4 and a median of $898736.0 in 2023 frame the typical range for Accumulated Depreciation & Amortization.
- Across the five-year window, Accumulated Depreciation & Amortization slumped 363.23% in 2022 and jumped 158.57% in 2023, its largest moves.
- BioNexus Gene Lab's Accumulated Depreciation & Amortization stood at -$1.5 million in 2022, then surged by 158.57% to $885004.0 in 2023, then increased by 11.09% to $983153.0 in 2024, then dropped by 3.95% to $944345.0 in 2025, then rose by 2.31% to $966160.0 in 2026.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $966160.0, $944345.0, and $971148.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 966,160.00 |
| Mar 31, 2026 | 966,160.00 |
| Dec 31, 2025 | 944,345.00 |
| Dec 31, 2025 | 944,345.00 |
| Sep 30, 2025 | 971,148.00 |
| Sep 30, 2025 | 971,148.00 |
| Jun 30, 2025 | 943,747.00 |
| Jun 30, 2025 | 943,747.00 |
| Mar 31, 2025 | 994,915.00 |
| Mar 31, 2025 | 994,915.00 |
| Dec 31, 2024 | 983,153.00 |
| Dec 31, 2024 | 983,153.00 |
| Sep 30, 2024 | 776,451.00 |
| Sep 30, 2024 | 776,451.00 |
| Jun 30, 2024 | 958,831.00 |
| Jun 30, 2024 | 958,831.00 |
| Mar 31, 2024 | 946,930.00 |
| Mar 31, 2024 | 946,930.00 |
| Dec 31, 2023 | 885,004.00 |
| Dec 31, 2023 | 885,004.00 |
| Sep 30, 2023 | 898,736.00 |
| Sep 30, 2023 | 898,736.00 |
| Jun 30, 2023 | 864,493.00 |
| Jun 30, 2023 | 864,493.00 |
| Mar 31, 2023 | 780,938.00 |
| Mar 31, 2023 | 780,938.00 |
| Dec 31, 2022 | -1.40 Mn |
| Dec 31, 2022 | -1.40 Mn |
| Sep 30, 2022 | 805,273.00 |
| Sep 30, 2022 | 805,273.00 |
| Jun 30, 2022 | 709,287.00 |
| Jun 30, 2022 | 709,287.00 |
| Mar 31, 2022 | -1.49 Mn |
| Mar 31, 2022 | -1.49 Mn |
| Dec 31, 2021 | 574,014.00 |
| Dec 31, 2021 | 574,014.00 |
| Sep 30, 2021 | -1.51 Mn |
| Sep 30, 2021 | -1.51 Mn |
| Jun 30, 2021 | -1.40 Mn |
| Jun 30, 2021 | -1.40 Mn |
| Mar 31, 2021 | -1.62 Mn |
| Mar 31, 2021 | -1.62 Mn |
| Dec 31, 2020 | -1.68 Mn |
| Dec 31, 2020 | -1.68 Mn |
| Dec 31, 2019 | -31,257.00 |
| Dec 31, 2019 | -31,257.00 |